chr2-227253440-T-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000091.5(COL4A3):c.687+103T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0533 in 1,423,358 control chromosomes in the GnomAD database, including 2,280 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.063 ( 332 hom., cov: 32)
Exomes 𝑓: 0.052 ( 1948 hom. )
Consequence
COL4A3
NM_000091.5 intron
NM_000091.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.421
Genes affected
COL4A3 (HGNC:2204): (collagen type IV alpha 3 chain) Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-227253440-T-A is Benign according to our data. Variant chr2-227253440-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 1172970.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0815 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0624 AC: 9501AN: 152148Hom.: 327 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9501
AN:
152148
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0591 AC: 14724AN: 249346 AF XY: 0.0603 show subpopulations
GnomAD2 exomes
AF:
AC:
14724
AN:
249346
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0522 AC: 66346AN: 1271090Hom.: 1948 Cov.: 18 AF XY: 0.0533 AC XY: 34287AN XY: 642940 show subpopulations
GnomAD4 exome
AF:
AC:
66346
AN:
1271090
Hom.:
Cov.:
18
AF XY:
AC XY:
34287
AN XY:
642940
show subpopulations
African (AFR)
AF:
AC:
2505
AN:
29654
American (AMR)
AF:
AC:
1697
AN:
44492
Ashkenazi Jewish (ASJ)
AF:
AC:
2540
AN:
24946
East Asian (EAS)
AF:
AC:
3417
AN:
38756
South Asian (SAS)
AF:
AC:
6835
AN:
82234
European-Finnish (FIN)
AF:
AC:
2545
AN:
53360
Middle Eastern (MID)
AF:
AC:
441
AN:
5406
European-Non Finnish (NFE)
AF:
AC:
43121
AN:
938156
Other (OTH)
AF:
AC:
3245
AN:
54086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
3458
6917
10375
13834
17292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0626 AC: 9528AN: 152268Hom.: 332 Cov.: 32 AF XY: 0.0638 AC XY: 4748AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
9528
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
4748
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
3483
AN:
41544
American (AMR)
AF:
AC:
871
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
341
AN:
3470
East Asian (EAS)
AF:
AC:
446
AN:
5180
South Asian (SAS)
AF:
AC:
362
AN:
4822
European-Finnish (FIN)
AF:
AC:
528
AN:
10624
Middle Eastern (MID)
AF:
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3272
AN:
68012
Other (OTH)
AF:
AC:
170
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
462
924
1385
1847
2309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
326
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Autosomal recessive Alport syndrome Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.